{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T23:11:47Z","timestamp":1782861107039,"version":"3.54.5"},"reference-count":131,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T00:00:00Z","timestamp":1746489600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T00:00:00Z","timestamp":1746489600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11033-025-10543-x","type":"journal-article","created":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T06:23:40Z","timestamp":1746512620000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["MicroRNAs modulation by curcumin, catalpol, and other natural products in Alzheimer\u2019s disease: a review"],"prefix":"10.1007","volume":"52","author":[{"given":"Amir Modarresi","family":"Chahardehi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Arefnezhad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Pourbafrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Tajik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Aref","family":"Asadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Salehi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saba","family":"Yazdanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma","family":"Nakhaee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrzad Sepahi","family":"Esfahani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parnian","family":"Behzad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helia","family":"Haghani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Niknam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niloofar","family":"Sefati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Rezaei-Tazangi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marziye Ranjbar","family":"Tavakoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,6]]},"reference":[{"issue":"1","key":"10543_CR1","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/s12974-020-01960-9","volume":"17","author":"S Sadeghmousavi","year":"2020","unstructured":"Sadeghmousavi S et al (2020) The effect of insomnia on development of Alzheimer\u2019s disease. J Neuroinflammation 17(1):289","journal-title":"J Neuroinflammation"},{"issue":"10","key":"10543_CR2","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1080\/00207454.2022.2045290","volume":"133","author":"ZX Phuna","year":"2023","unstructured":"Phuna ZX, Madhavan P (2023) A reappraisal on amyloid cascade hypothesis: the role of chronic infection in Alzheimer\u2019s disease. Int J Neurosci 133(10):1071\u20131089","journal-title":"Int J Neurosci"},{"key":"10543_CR3","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.3389\/fgene.2019.01368","volume":"10","author":"VP Bajic","year":"2019","unstructured":"Bajic VP et al (2019) The X files: the mystery of X chromosome instability in Alzheimer\u2019s disease. Front Genet 10:1368","journal-title":"Front Genet"},{"issue":"10284","key":"10543_CR4","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","volume":"397","author":"P Scheltens","year":"2021","unstructured":"Scheltens P et al (2021) Alzheimer\u2019s disease. Lancet 397(10284):1577\u20131590","journal-title":"Lancet"},{"issue":"6","key":"10543_CR5","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1037\/neu0000907","volume":"37","author":"GA Carlesimo","year":"2023","unstructured":"Carlesimo GA, De Simone MS (2023) Special issue on novel neuropsychological instruments for the prodromal and preclinical diagnosis of Alzheimer\u2019s disease. Neuropsychology 37(6):623\u2013627","journal-title":"Neuropsychology"},{"issue":"10 Suppl","key":"10543_CR6","first-page":"S188","volume":"28","author":"AP Skaria","year":"2022","unstructured":"Skaria AP (2022) The economic and societal burden of alzheimer disease: managed care considerations. Am J Manag Care 28(10 Suppl):S188\u2013S196","journal-title":"Am J Manag Care"},{"key":"10543_CR7","doi-asserted-by":"crossref","unstructured":"Smolarz B et al (2022) MiRNAs in Cancer (Review of Literature). Int J Mol Sci, 23(5)","DOI":"10.3390\/ijms23052805"},{"issue":"18","key":"10543_CR8","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1007\/s00213-016-4379-6","volume":"233","author":"S Reeves","year":"2016","unstructured":"Reeves S et al (2016) A population approach to characterise Amisulpride pharmacokinetics in older people and Alzheimer\u2019s disease. Psychopharmacology 233(18):3371\u20133381","journal-title":"Psychopharmacology"},{"key":"10543_CR9","doi-asserted-by":"crossref","first-page":"884345","DOI":"10.3389\/fnins.2022.884345","volume":"16","author":"BA Bhat","year":"2022","unstructured":"Bhat BA et al (2022) Natural therapeutics in aid of treating Alzheimer\u2019s disease: A green gateway toward ending quest for treating neurological disorders. Front Neurosci 16:884345","journal-title":"Front Neurosci"},{"issue":"8","key":"10543_CR10","doi-asserted-by":"crossref","first-page":"870","DOI":"10.2174\/1567205014666170317113606","volume":"14","author":"C Domingues","year":"2017","unstructured":"Domingues C, E.S.O.A.B. da Cruz, Henriques AG (2017) Impact of cytokines and chemokines on Alzheimer\u2019s disease neuropathological hallmarks. Curr Alzheimer Res 14(8):870\u2013882","journal-title":"Curr Alzheimer Res"},{"issue":"3","key":"10543_CR11","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1515\/tjb-2023-0049","volume":"48","author":"G \u00d6ztan","year":"2023","unstructured":"\u00d6ztan G, \u0130\u015fsever H (2023) Molecular mechanisms and genetics of Alzheimer\u2019s disease. Turkish J Biochem 48(3):218\u2013229","journal-title":"Turkish J Biochem"},{"key":"10543_CR12","doi-asserted-by":"crossref","unstructured":"Barati M, Chahardehi AM (2023) Alkaloids: The Potential of Their Antimicrobial Activities of Medicinal Plants, in Medicinal Plants-Chemical, Biochemical, and Pharmacological Approaches. IntechOpen","DOI":"10.5772\/intechopen.112364"},{"key":"10543_CR13","doi-asserted-by":"crossref","unstructured":"Saadati F et al (2024) Coumarin: A natural solution for alleviating inflammatory disorders. Curr Res Pharmacol Drug Discovery,: p. 100202","DOI":"10.1016\/j.crphar.2024.100202"},{"key":"10543_CR14","doi-asserted-by":"crossref","unstructured":"Modarresi Chahardehi A et al (2024) MicroRNAs and angiosarcoma: are there promising reports? Frontiers in Oncology","DOI":"10.3389\/fonc.2024.1385632"},{"key":"10543_CR15","doi-asserted-by":"crossref","first-page":"116029","DOI":"10.1016\/j.biopha.2023.116029","volume":"170","author":"C Mu","year":"2024","unstructured":"Mu C et al (2024) Mechanisms of microRNA-132 in central neurodegenerative diseases: A comprehensive review. Biomed Pharmacother 170:116029","journal-title":"Biomed Pharmacother"},{"key":"10543_CR16","doi-asserted-by":"crossref","unstructured":"Gugliandolo A et al (2020) MicroRNAs Modulate the Pathogenesis of Alzheimer\u2019s Disease: An In Silico Analysis in the Human Brain. Genes (Basel) 11(9)","DOI":"10.3390\/genes11090983"},{"key":"10543_CR17","doi-asserted-by":"crossref","first-page":"102481","DOI":"10.1016\/j.arr.2024.102481","volume":"101","author":"PT Kamatham","year":"2024","unstructured":"Kamatham PT et al (2024) Pathogenesis, diagnostics, and therapeutics for Alzheimer\u2019s disease: breaking the memory barrier. Ageing Res Rev 101:102481","journal-title":"Ageing Res Rev"},{"issue":"1","key":"10543_CR18","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/s41398-024-03075-8","volume":"14","author":"Y-B Li","year":"2024","unstructured":"Li Y-B et al (2024) MicroRNAs: pioneering regulators in Alzheimer\u2019s disease pathogenesis, diagnosis, and therapy. Translational Psychiatry 14(1):367","journal-title":"Translational Psychiatry"},{"issue":"1","key":"10543_CR19","first-page":"20","volume":"42","author":"Y Liu","year":"2019","unstructured":"Liu Y et al (2019) The targeting of non\u2013coding RNAs by Curcumin: facts and hopes for cancer therapy (Review). Oncol Rep 42(1):20\u201334","journal-title":"Oncol Rep"},{"issue":"4","key":"10543_CR20","first-page":"430","volume":"14","author":"F Rezaei-Tazangi","year":"2024","unstructured":"Rezaei-Tazangi F, Mirhosseini AF, Fathi A, Roghani-Shahraki H, Arefnezhad R, Vasei F (2024) Herbal and nano-based herbal medicine: new insights into their therapeutic aspects against periodontitis. Avicenna J Phytomedicine 14(4):430","journal-title":"Avicenna J Phytomedicine"},{"key":"10543_CR21","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3389\/fgene.2019.00514","volume":"10","author":"FU Hassan","year":"2019","unstructured":"Hassan FU et al (2019) Curcumin as an alternative epigenetic modulator: mechanism of action and potential effects. Front Genet 10:514","journal-title":"Front Genet"},{"issue":"5","key":"10543_CR22","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s42452-024-05811-7","volume":"6","author":"S Bordoloi","year":"2024","unstructured":"Bordoloi S et al (2024) Some promising medicinal plants used in Alzheimer\u2019s disease: an ethnopharmacological perspective. Discover Appl Sci 6(5):215","journal-title":"Discover Appl Sci"},{"issue":"4","key":"10543_CR23","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/biof.2039","volume":"50","author":"T Abdul-Rahman","year":"2024","unstructured":"Abdul-Rahman T et al (2024) Antioxidant, anti-inflammatory and epigenetic potential of Curcumin in Alzheimer\u2019s disease. BioFactors 50(4):693\u2013708","journal-title":"BioFactors"},{"issue":"10","key":"10543_CR24","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.2174\/0929867322666150114151720","volume":"22","author":"B Jiang","year":"2015","unstructured":"Jiang B et al (2015) Catalpol: a potential therapeutic for neurodegenerative diseases. Curr Med Chem 22(10):1278\u20131291","journal-title":"Curr Med Chem"},{"issue":"3","key":"10543_CR25","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.neulet.2008.07.029","volume":"442","author":"J Bi","year":"2008","unstructured":"Bi J et al (2008) Protective effects of Catalpol against H2O2-induced oxidative stress in astrocytes primary cultures. Neurosci Lett 442(3):224\u2013227","journal-title":"Neurosci Lett"},{"issue":"10","key":"10543_CR26","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.jpha.2023.06.010","volume":"13","author":"Z Zhang","year":"2023","unstructured":"Zhang Z et al (2023) Protective effects of Catalpol on cardio-cerebrovascular diseases: A comprehensive review. J Pharm Anal 13(10):1089\u20131101","journal-title":"J Pharm Anal"},{"key":"10543_CR27","doi-asserted-by":"crossref","unstructured":"Chen H et al (2022) Effects of Catalpol on Alzheimer\u2019s Disease and Its Mechanisms. Evid Based Complement Alternat Med, 2022: p. 2794243","DOI":"10.1155\/2022\/2794243"},{"key":"10543_CR28","doi-asserted-by":"crossref","first-page":"137491","DOI":"10.1016\/j.neulet.2023.137491","volume":"815","author":"F Kamranfar","year":"2023","unstructured":"Kamranfar F et al (2023) Protective effect of a standardized Allium jesdianum extract in an Alzheimer\u2019s disease induced rat model. Neurosci Lett 815:137491","journal-title":"Neurosci Lett"},{"key":"10543_CR29","doi-asserted-by":"crossref","first-page":"176003","DOI":"10.1016\/j.ejphar.2023.176003","volume":"957","author":"Q You","year":"2023","unstructured":"You Q et al (2023) Neuroprotective strategies for neonatal hypoxic-ischemic brain damage: current status and challenges. Eur J Pharmacol 957:176003","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"10543_CR30","doi-asserted-by":"crossref","first-page":"563","DOI":"10.5498\/wjp.v14.i4.563","volume":"14","author":"LX Yang","year":"2024","unstructured":"Yang LX, Luo M, Li SY (2024) Tanshinone IIA improves Alzheimer\u2019s disease via RNA nuclear-enriched abundant transcript 1\/microRNA-291a-3p\/member RAS oncogene family Rab22a axis. World J Psychiatry 14(4):563\u2013581","journal-title":"World J Psychiatry"},{"key":"10543_CR31","doi-asserted-by":"crossref","unstructured":"Sudha S et al (2024) Pharmacological impacts of Tanshinone on osteogenesis and osteoclastogenesis: a review. Naunyn Schmiedebergs Arch Pharmacol","DOI":"10.1007\/s00210-024-03351-w"},{"issue":"2","key":"10543_CR32","doi-asserted-by":"crossref","first-page":"689","DOI":"10.3892\/mmr.2014.2254","volume":"10","author":"P Jiang","year":"2014","unstructured":"Jiang P et al (2014) Tanshinone IIA reduces the risk of Alzheimer\u2019s disease by inhibiting iNOS, MMP\u20132 and NF\u2013\u03baBp65 transcription and translation in the Temporal lobes of rat models of Alzheimer\u2019s disease. Mol Med Rep 10(2):689\u2013694","journal-title":"Mol Med Rep"},{"issue":"2","key":"10543_CR33","doi-asserted-by":"crossref","first-page":"e23648","DOI":"10.1002\/jbt.23648","volume":"38","author":"Q Li","year":"2024","unstructured":"Li Q et al (2024) Tanshinone IIA regulates CCl(4) induced liver fibrosis in C57BL\/6J mice via the PI3K\/Akt and Nrf2\/HO-1 signaling pathways. J Biochem Mol Toxicol 38(2):e23648","journal-title":"J Biochem Mol Toxicol"},{"issue":"7","key":"10543_CR34","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1142\/S0192415X23500805","volume":"51","author":"P Ji","year":"2023","unstructured":"Ji P et al (2023) A novel paradigm defines functional molecule clusters for an Anti-Alzheimer\u2019s disease recipe from traditional Chinese medicine. Am J Chin Med 51(7):1823\u20131843","journal-title":"Am J Chin Med"},{"issue":"8","key":"10543_CR35","first-page":"603","volume":"23","author":"H Qiu","year":"2003","unstructured":"Qiu H, Jin GQ, Zhao WK (2003) Establishment of analogous oxidative damaged Alzheimer\u2019s disease rat model and effect of Tiaoxin recipe on it]. Zhongguo Zhong Xi Yi Jie He Za Zhi 23(8):603\u2013605","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"issue":"3","key":"10543_CR36","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3233\/JAD-170512","volume":"61","author":"PH Reddy","year":"2018","unstructured":"Reddy PH et al (2018) Protective effects of Indian spice Curcumin against Amyloid-beta in Alzheimer\u2019s disease. J Alzheimers Dis 61(3):843\u2013866","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"10543_CR37","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1515\/jbcpp-2016-0147","volume":"28","author":"TT Bui","year":"2017","unstructured":"Bui TT, Nguyen TH (2017) Natural product for the treatment of Alzheimer\u2019s disease. J Basic Clin Physiol Pharmacol 28(5):413\u2013423","journal-title":"J Basic Clin Physiol Pharmacol"},{"issue":"4","key":"10543_CR38","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.3390\/nu13041318","volume":"13","author":"T Benameur","year":"2021","unstructured":"Benameur T, Soleti R, Porro C (2021) The potential neuroprotective role of free and encapsulated Quercetin mediated by MiRNA against neurological diseases. Nutrients 13(4):1318","journal-title":"Nutrients"},{"issue":"26","key":"10543_CR39","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.2174\/0929867323666161213101126","volume":"25","author":"LC Dos Santos Picanco","year":"2018","unstructured":"Dos Santos Picanco LC et al (2018) Alzheimer\u2019s disease: A review from the pathophysiology to diagnosis, new perspectives for Pharmacological treatment. Curr Med Chem 25(26):3141\u20133159","journal-title":"Curr Med Chem"},{"issue":"1","key":"10543_CR40","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/s12906-022-03816-6","volume":"22","author":"M Pourhadi","year":"2022","unstructured":"Pourhadi M et al (2022) Cuscuta epithymum murr. Crude extract pre-conditioning protects C6 cells from L-glutamate-induced neurotoxicity. BMC Complement Med Ther 22(1):335","journal-title":"BMC Complement Med Ther"},{"key":"10543_CR41","doi-asserted-by":"crossref","unstructured":"Mohebichamkhorami F et al (2022) Brain homogenate of a rat model of Alzheimer\u2019s disease modifies the secretome of 3D cultured periodontal ligament stem cells: A potential neuroregenerative therapy. Iran J Pharm Research: IJPR 21(1)","DOI":"10.5812\/ijpr-133668"},{"issue":"1","key":"10543_CR42","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1186\/s13287-022-02942-9","volume":"13","author":"F Mohebichamkhorami","year":"2022","unstructured":"Mohebichamkhorami F et al (2022) Periodontal ligament stem cells as a promising therapeutic target for neural damage. Stem Cell Res Ther 13(1):273","journal-title":"Stem Cell Res Ther"},{"key":"10543_CR43","doi-asserted-by":"crossref","unstructured":"Genchi G et al (2024) Neuroprotective effects of Curcumin in neurodegenerative diseases. Foods 13(11)","DOI":"10.3390\/foods13111774"},{"key":"10543_CR44","doi-asserted-by":"crossref","first-page":"937486","DOI":"10.3389\/fnagi.2022.937486","volume":"14","author":"X Li","year":"2022","unstructured":"Li X et al (2022) Global, regional, and National burden of Alzheimer\u2019s disease and other dementias, 1990\u20132019. Front Aging Neurosci 14:937486","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"10543_CR45","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3390\/ijms24010107","volume":"24","author":"AA Rostagno","year":"2023","unstructured":"Rostagno AA (2023) Pathogenesis of Alzheimer\u2019s disease. Int J Mol Sci 24(1):107","journal-title":"Int J Mol Sci"},{"issue":"70","key":"10543_CR46","doi-asserted-by":"crossref","first-page":"13434","DOI":"10.1039\/C5CC05264E","volume":"51","author":"K Rajasekhar","year":"2015","unstructured":"Rajasekhar K, Chakrabarti M, Govindaraju T (2015) Function and toxicity of amyloid beta and recent therapeutic interventions targeting amyloid beta in Alzheimer\u2019s disease. Chem Commun (Camb) 51(70):13434\u201313450","journal-title":"Chem Commun (Camb)"},{"issue":"1","key":"10543_CR47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000369101","volume":"24","author":"S Sadigh-Eteghad","year":"2015","unstructured":"Sadigh-Eteghad S et al (2015) Amyloid-beta: a crucial factor in Alzheimer\u2019s disease. Med Princ Pract 24(1):1\u201310","journal-title":"Med Princ Pract"},{"key":"10543_CR48","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neulet.2018.08.016","volume":"685","author":"M Wang","year":"2018","unstructured":"Wang M et al (2018) Beta-secretase\/BACE1 promotes APP endocytosis and processing in the endosomes and on cell membrane. Neurosci Lett 685:63\u201367","journal-title":"Neurosci Lett"},{"issue":"46","key":"10543_CR49","doi-asserted-by":"crossref","first-page":"38408","DOI":"10.1074\/jbc.M112.415505","volume":"287","author":"B Hitt","year":"2012","unstructured":"Hitt B et al (2012) \u03b2-Site amyloid precursor protein (APP)-cleaving enzyme 1 (BACE1)-deficient mice exhibit a close homolog of L1 (CHL1) Loss-of-function phenotype involving axon guidance defects. J Biol Chem 287(46):38408\u201338425","journal-title":"J Biol Chem"},{"issue":"2","key":"10543_CR50","first-page":"1565","volume":"8","author":"X Lei","year":"2015","unstructured":"Lei X et al (2015) Downregulated miR-29c correlates with increased BACE1 expression in sporadic Alzheimer\u2019s disease. Int J Clin Exp Pathol 8(2):1565\u20131574","journal-title":"Int J Clin Exp Pathol"},{"key":"10543_CR51","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.neuropharm.2016.04.046","volume":"108","author":"Y Jiao","year":"2016","unstructured":"Jiao Y et al (2016) Osthole decreases beta amyloid levels through up-regulation of miR-107 in Alzheimer\u2019s disease. Neuropharmacology 108:332\u2013344","journal-title":"Neuropharmacology"},{"issue":"1","key":"10543_CR52","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nn.4188","volume":"19","author":"U Das","year":"2016","unstructured":"Das U et al (2016) Visualizing APP and BACE-1 approximation in neurons yields insight into the amyloidogenic pathway. Nat Neurosci 19(1):55\u201364","journal-title":"Nat Neurosci"},{"issue":"21","key":"10543_CR53","first-page":"4020","volume":"19","author":"B Zhang","year":"2015","unstructured":"Zhang B et al (2015) MiR-16 regulates cell death in Alzheimer\u2019s disease by targeting amyloid precursor protein. Eur Rev Med Pharmacol Sci 19(21):4020\u20134027","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10543_CR54","doi-asserted-by":"crossref","unstructured":"Wang L et al (2023) Potential Implications of miRNAs in the Pathogenesis, Diagnosis, and Therapeutics of Alzheimer\u2019s Disease. Int J Mol Sci 24(22)","DOI":"10.3390\/ijms242216259"},{"issue":"9","key":"10543_CR55","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.7150\/thno.53418","volume":"11","author":"C Liang","year":"2021","unstructured":"Liang C et al (2021) MicroRNA-146a switches microglial phenotypes to resist the pathological processes and cognitive degradation of Alzheimer\u2019s disease. Theranostics 11(9):4103\u20134121","journal-title":"Theranostics"},{"issue":"23","key":"10543_CR56","doi-asserted-by":"crossref","first-page":"6721","DOI":"10.1093\/hmg\/ddv377","volume":"24","author":"PY Smith","year":"2015","unstructured":"Smith PY et al (2015) miR-132\/212 deficiency impairs Tau metabolism and promotes pathological aggregation in vivo. Hum Mol Genet 24(23):6721\u20136735","journal-title":"Hum Mol Genet"},{"issue":"2","key":"10543_CR57","doi-asserted-by":"crossref","first-page":"85","DOI":"10.21037\/atm-21-6601","volume":"10","author":"Y Shao","year":"2022","unstructured":"Shao Y, Xu T (2022) A study on the neuroprotective effect of miR-206-3p on Alzheimer\u2019s disease mice by regulating brain-derived neurotrophic factor. Ann Transl Med 10(2):85","journal-title":"Ann Transl Med"},{"issue":"69","key":"10543_CR58","doi-asserted-by":"crossref","first-page":"114065","DOI":"10.18632\/oncotarget.23119","volume":"8","author":"F An","year":"2017","unstructured":"An F et al (2017) MiR-124 acts as a target for Alzheimer\u2019s disease by regulating BACE1. Oncotarget 8(69):114065\u2013114071","journal-title":"Oncotarget"},{"issue":"41","key":"10543_CR59","doi-asserted-by":"crossref","first-page":"14820","DOI":"10.1523\/JNEUROSCI.3883-11.2011","volume":"31","author":"H Geekiyanage","year":"2011","unstructured":"Geekiyanage H, Chan C (2011) MicroRNA-137\/181c regulates Serine palmitoyltransferase and in turn amyloid beta, novel targets in sporadic Alzheimer\u2019s disease. J Neurosci 31(41):14820\u201314830","journal-title":"J Neurosci"},{"key":"10543_CR60","doi-asserted-by":"crossref","unstructured":"Shi H, Zhao Y (2024) Modulation of Tau Pathology in Alzheimer\u2019s Disease by Dietary Bioactive Compounds. Int J Mol Sci, 25(2)","DOI":"10.3390\/ijms25020831"},{"key":"10543_CR61","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3389\/fncel.2018.00338","volume":"12","author":"AD Alonso","year":"2018","unstructured":"Alonso AD et al (2018) Hyperphosphorylation of Tau associates with changes in its function beyond microtubule stability. Front Cell Neurosci 12:338","journal-title":"Front Cell Neurosci"},{"issue":"6","key":"10543_CR62","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.5114\/aoms.2015.56342","volume":"11","author":"S Bathina","year":"2015","unstructured":"Bathina S, Das UN (2015) Brain-derived neurotrophic factor and its clinical implications. Arch Med Sci 11(6):1164\u20131178","journal-title":"Arch Med Sci"},{"issue":"15","key":"10543_CR63","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.15252\/embj.201387576","volume":"33","author":"J Banzhaf-Strathmann","year":"2014","unstructured":"Banzhaf-Strathmann J et al (2014) MicroRNA-125b induces Tau hyperphosphorylation and cognitive deficits in Alzheimer\u2019s disease. EMBO J 33(15):1667\u20131680","journal-title":"EMBO J"},{"issue":"6","key":"10543_CR64","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.febslet.2015.02.001","volume":"589","author":"X Wang","year":"2015","unstructured":"Wang X et al (2015) MicroRNA-138 promotes Tau phosphorylation by targeting retinoic acid receptor alpha. FEBS Lett 589(6):726\u2013729","journal-title":"FEBS Lett"},{"key":"10543_CR65","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.neuroscience.2014.06.013","volume":"275","author":"ZB Zhao","year":"2014","unstructured":"Zhao ZB et al (2014) MicroRNA-922 promotes Tau phosphorylation by downregulating ubiquitin carboxy-terminal hydrolase L1 (UCHL1) expression in the pathogenesis of Alzheimer\u2019s disease. Neuroscience 275:232\u2013237","journal-title":"Neuroscience"},{"key":"10543_CR66","doi-asserted-by":"crossref","first-page":"26697","DOI":"10.1038\/srep26697","volume":"6","author":"G Wang","year":"2016","unstructured":"Wang G et al (2016) MicroRNA-146a suppresses ROCK1 allowing hyperphosphorylation of Tau in Alzheimer\u2019s disease. Sci Rep 6:26697","journal-title":"Sci Rep"},{"key":"10543_CR67","doi-asserted-by":"crossref","first-page":"146327","DOI":"10.1016\/j.brainres.2019.146327","volume":"1721","author":"S Sarkar","year":"2019","unstructured":"Sarkar S et al (2019) Over-expression of miR-34a induces rapid cognitive impairment and Alzheimer\u2019s disease-like pathology. Brain Res 1721:146327","journal-title":"Brain Res"},{"issue":"2","key":"10543_CR68","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1172\/JCI78421","volume":"125","author":"I Santa-Maria","year":"2015","unstructured":"Santa-Maria I et al (2015) Dysregulation of microRNA-219 promotes neurodegeneration through post-transcriptional regulation of Tau. J Clin Invest 125(2):681\u2013686","journal-title":"J Clin Invest"},{"key":"10543_CR69","doi-asserted-by":"crossref","first-page":"e256","DOI":"10.1038\/mtna.2015.33","volume":"4","author":"S Parsi","year":"2015","unstructured":"Parsi S et al (2015) Preclinical evaluation of miR-15\/107 family members as multifactorial drug targets for Alzheimer\u2019s disease. Mol Therapy - Nucleic Acids 4:e256","journal-title":"Mol Therapy - Nucleic Acids"},{"issue":"1","key":"10543_CR70","first-page":"2638130","volume":"2020","author":"A Nunomura","year":"2020","unstructured":"Nunomura A, Perry G (2020) RNA and oxidative stress in Alzheimer\u2019s disease: focus on MicroRNAs. Oxidative Med Cell Longev 2020(1):2638130","journal-title":"Oxidative Med Cell Longev"},{"issue":"8","key":"10543_CR71","first-page":"4179","volume":"11","author":"J Zhu","year":"2018","unstructured":"Zhu J et al (2018) Overexpression of miR-153 promotes oxidative stress in MPP(+)-induced PD model by negatively regulating the Nrf2\/HO-1 signaling pathway. Int J Clin Exp Pathol 11(8):4179\u20134187","journal-title":"Int J Clin Exp Pathol"},{"key":"10543_CR72","first-page":"323","volume":"3","author":"KN Holohan","year":"2012","unstructured":"Holohan KN et al (2012) Functional MicroRNAs in Alzheimer\u2019s disease and cancer: differential regulation of common mechanisms and pathways. Front Genet 3:323","journal-title":"Front Genet"},{"key":"10543_CR73","doi-asserted-by":"crossref","unstructured":"Nunomura A, Perry G (2020) RNA and Oxidative Stress in Alzheimer\u2019s Disease: Focus on microRNAs. Oxid Med Cell Longev, 2020: p. 2638130","DOI":"10.1155\/2020\/2638130"},{"key":"10543_CR74","unstructured":"Zhan-Qiang H et al (2021) miR-146a aggravates cognitive impairment and alzheimer disease-like pathology by triggering oxidative stress through MAPK signaling. Neurologia (Engl Ed)"},{"issue":"6","key":"10543_CR75","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.brainresbull.2012.05.018","volume":"88","author":"HC Zhu","year":"2012","unstructured":"Zhu HC et al (2012) MicroRNA-195 downregulates Alzheimer\u2019s disease amyloid-beta production by targeting BACE1. Brain Res Bull 88(6):596\u2013601","journal-title":"Brain Res Bull"},{"issue":"1","key":"10543_CR76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.9758\/cpn.2017.15.1.1","volume":"15","author":"S Kocahan","year":"2017","unstructured":"Kocahan S, Dogan Z (2017) Mechanisms of Alzheimer\u2019s disease pathogenesis and prevention: the brain, neural pathology, N-methyl-D-aspartate receptors, Tau protein and other risk factors. Clin Psychopharmacol Neurosci 15(1):1\u20138","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"10543_CR77","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3389\/fnagi.2017.00214","volume":"9","author":"AI Ramirez","year":"2017","unstructured":"Ramirez AI et al (2017) The role of microglia in retinal neurodegeneration: Alzheimer\u2019s disease, Parkinson, and Glaucoma. Front Aging Neurosci 9:214","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"10543_CR78","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13024-020-00391-7","volume":"15","author":"T Guo","year":"2020","unstructured":"Guo T et al (2020) Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer\u2019s disease. Mol Neurodegeneration 15(1):40","journal-title":"Mol Neurodegeneration"},{"issue":"2","key":"10543_CR79","doi-asserted-by":"crossref","first-page":"111","DOI":"10.31887\/DCNS.2009.11.2\/cqiu","volume":"11","author":"C Qiu","year":"2009","unstructured":"Qiu C, Kivipelto M, von Strauss E (2009) Epidemiology of Alzheimer\u2019s disease: occurrence, determinants, and strategies toward intervention. Dialogues Clin Neurosci 11(2):111\u2013128","journal-title":"Dialogues Clin Neurosci"},{"key":"10543_CR80","doi-asserted-by":"crossref","first-page":"156724","DOI":"10.1016\/j.cyto.2024.156724","volume":"182","author":"SM Aghaei","year":"2024","unstructured":"Aghaei SM, Hosseini SM (2024) Inflammation-related MiRNAs in obesity, CVD, and NAFLD. Cytokine 182:156724","journal-title":"Cytokine"},{"issue":"4","key":"10543_CR81","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41435-024-00283-6","volume":"25","author":"P Artimovi\u010d","year":"2024","unstructured":"Artimovi\u010d P et al (2024) The ability of MicroRNAs to regulate the immune response in ischemia\/reperfusion inflammatory pathways. Genes Immun 25(4):277\u2013296","journal-title":"Genes Immun"},{"key":"10543_CR82","doi-asserted-by":"crossref","unstructured":"Das K, Rao LVM (2022) The role of MicroRNAs in inflammation. Int J Mol Sci, 23(24)","DOI":"10.3390\/ijms232415479"},{"issue":"13","key":"10543_CR83","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.3390\/cells12131749","volume":"12","author":"Y Zhang","year":"2023","unstructured":"Zhang Y et al (2023) Role of MiRNAs in rheumatoid arthritis therapy. Cells 12(13):1749","journal-title":"Cells"},{"issue":"8","key":"10543_CR84","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.3390\/biom12081072","volume":"12","author":"S-C Yang","year":"2022","unstructured":"Yang S-C et al (2022) Anti-Inflammatory MicroRNAs for treating inflammatory skin diseases. Biomolecules 12(8):1072","journal-title":"Biomolecules"},{"key":"10543_CR85","doi-asserted-by":"crossref","first-page":"852419","DOI":"10.3389\/fimmu.2022.852419","volume":"13","author":"Y Jiang","year":"2022","unstructured":"Jiang Y et al (2022) The role of MicroRNA in the inflammatory response of wound healing. Front Immunol 13:852419","journal-title":"Front Immunol"},{"key":"10543_CR86","doi-asserted-by":"crossref","unstructured":"Zapata-Mart\u00ednez L et al (2023) Inflammatory MicroRNAs in cardiovascular pathology: another brick in the wall. Front Immunol, 14","DOI":"10.3389\/fimmu.2023.1196104"},{"key":"10543_CR87","doi-asserted-by":"crossref","first-page":"1391537","DOI":"10.3389\/fncel.2024.1391537","volume":"18","author":"SP Jadhav","year":"2024","unstructured":"Jadhav SP (2024) MicroRNAs in microglia: Deciphering their role in neurodegenerative diseases. Front Cell Neurosci 18:1391537","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"10543_CR88","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13024-021-00496-7","volume":"16","author":"H Walgrave","year":"2021","unstructured":"Walgrave H et al (2021) The promise of microRNA-based therapies in Alzheimer\u2019s disease: challenges and perspectives. Mol Neurodegeneration 16(1):76","journal-title":"Mol Neurodegeneration"},{"key":"10543_CR89","doi-asserted-by":"crossref","first-page":"1231486","DOI":"10.3389\/fgene.2023.1231486","volume":"14","author":"SZ Abidin","year":"2023","unstructured":"Abidin SZ et al (2023) A new perspective on Alzheimer\u2019s disease: MicroRNAs and circular RNAs. Front Genet 14:1231486","journal-title":"Front Genet"},{"key":"10543_CR90","doi-asserted-by":"crossref","first-page":"785433","DOI":"10.3389\/fncel.2021.785433","volume":"15","author":"Y Liang","year":"2021","unstructured":"Liang Y, Wang L (2021) Inflamma-MicroRNAs in Alzheimer\u2019s disease: from disease pathogenesis to therapeutic potentials. Front Cell Neurosci 15:785433","journal-title":"Front Cell Neurosci"},{"key":"10543_CR91","doi-asserted-by":"crossref","unstructured":"Lee CY et al (2021) miRNAs as Therapeutic Tools in Alzheimer\u2019s Disease. Int J Mol Sci, 22(23)","DOI":"10.3390\/ijms222313012"},{"issue":"2","key":"10543_CR92","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1096\/fj.201601308","volume":"31","author":"E Salta","year":"2017","unstructured":"Salta E, De Strooper B (2017) microRNA-132: a key noncoding RNA operating in the cellular phase of Alzheimer\u2019s disease. FASEB J 31(2):424\u2013433","journal-title":"FASEB J"},{"issue":"1","key":"10543_CR93","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s11011-023-01265-9","volume":"39","author":"S Kaur","year":"2024","unstructured":"Kaur S et al (2024) Understanding the multifaceted role of MiRNAs in Alzheimer\u2019s disease pathology. Metab Brain Dis 39(1):217\u2013237","journal-title":"Metab Brain Dis"},{"key":"10543_CR94","doi-asserted-by":"crossref","unstructured":"Nguyen TPN et al (2022) MicroRNA alteration, application as biomarkers, and therapeutic approaches in neurodegenerative diseases. Int J Mol Sci, 23(9).","DOI":"10.3390\/ijms23094718"},{"key":"10543_CR95","doi-asserted-by":"crossref","unstructured":"Wei W et al (2020) MicroRNAs in Alzheimer\u2019s disease: function and potential applications as diagnostic biomarkers. Front Mol Neurosci, 13","DOI":"10.3389\/fnmol.2020.00160"},{"key":"10543_CR96","doi-asserted-by":"crossref","unstructured":"Liu S et al (2022) MicroRNAs in Alzheimer\u2019s disease: Potential diagnostic markers and therapeutic targets, Biomedicine & Pharmacotherapy, 148:112681","DOI":"10.1016\/j.biopha.2022.112681"},{"issue":"1","key":"10543_CR97","doi-asserted-by":"crossref","first-page":"8465","DOI":"10.1038\/s41598-018-26547-6","volume":"8","author":"A Hadar","year":"2018","unstructured":"Hadar A et al (2018) SIRT1, miR-132 and miR-212 link human longevity to Alzheimer\u2019s disease. Sci Rep 8(1):8465","journal-title":"Sci Rep"},{"key":"10543_CR98","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.brainres.2016.05.026","volume":"1646","author":"S Sarkar","year":"2016","unstructured":"Sarkar S et al (2016) Expression of microRNA-34a in Alzheimer\u2019s disease brain targets genes linked to synaptic plasticity, energy metabolism, and resting state network activity. Brain Res 1646:139\u2013151","journal-title":"Brain Res"},{"key":"10543_CR99","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3389\/fnagi.2015.00061","volume":"7","author":"J Song","year":"2015","unstructured":"Song J, Lee JE (2015) miR-155 is involved in Alzheimer\u2019s disease by regulating T lymphocyte function. Front Aging Neurosci 7:61","journal-title":"Front Aging Neurosci"},{"issue":"2","key":"10543_CR100","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s12264-013-1419-7","volume":"30","author":"N Tian","year":"2014","unstructured":"Tian N, Cao Z, Zhang Y (2014) MiR-206 decreases brain-derived neurotrophic factor levels in a Transgenic mouse model of Alzheimer\u2019s disease. Neurosci Bull 30(2):191\u2013197","journal-title":"Neurosci Bull"},{"issue":"6","key":"10543_CR101","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1586\/14737175.2015.1044981","volume":"15","author":"S Hu","year":"2015","unstructured":"Hu S et al (2015) Clinical development of Curcumin in neurodegenerative disease. Expert Rev Neurother 15(6):629\u2013637","journal-title":"Expert Rev Neurother"},{"issue":"1","key":"10543_CR102","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1021\/acs.jcim.9b00561","volume":"60","author":"JM Jakubowski","year":"2020","unstructured":"Jakubowski JM et al (2020) Interactions between Curcumin derivatives and Amyloid-beta fibrils: insights from molecular dynamics simulations. J Chem Inf Model 60(1):289\u2013305","journal-title":"J Chem Inf Model"},{"key":"10543_CR103","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.nbd.2019.02.015","volume":"127","author":"B Teter","year":"2019","unstructured":"Teter B et al (2019) Curcumin restores innate immune alzheimer\u2019s disease risk gene expression to ameliorate alzheimer pathogenesis. Neurobiol Dis 127:432\u2013448","journal-title":"Neurobiol Dis"},{"issue":"1","key":"10543_CR104","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4103\/0972-2327.40220","volume":"11","author":"S Mishra","year":"2008","unstructured":"Mishra S, Palanivelu K (2008) The effect of Curcumin (turmeric) on Alzheimer\u2019s disease: an overview. Ann Indian Acad Neurol 11(1):13\u201319","journal-title":"Ann Indian Acad Neurol"},{"issue":"5","key":"10543_CR105","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2174\/1567205012666150504151120","volume":"12","author":"P Zhai","year":"2015","unstructured":"Zhai P et al (2015) Syntheses and evaluation of asymmetric Curcumin analogues as potential multifunctional agents for the treatment of Alzheimer\u2019s disease. Curr Alzheimer Res 12(5):403\u2013414","journal-title":"Curr Alzheimer Res"},{"issue":"1","key":"10543_CR106","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/alz.12683","volume":"19","author":"T Ashleigh","year":"2023","unstructured":"Ashleigh T, Swerdlow RH, Beal MF (2023) The role of mitochondrial dysfunction in Alzheimer\u2019s disease pathogenesis. Alzheimers Dement 19(1):333\u2013342","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10543_CR107","first-page":"1","volume":"9","author":"N Kandezi","year":"2020","unstructured":"Kandezi N et al (2020) Novel insight to neuroprotective potential of Curcumin: A mechanistic review of possible involvement of mitochondrial biogenesis and PI3\/Akt\/ GSK3 or PI3\/Akt\/CREB\/BDNF signaling pathways. Int J Mol Cell Med 9(1):1\u201332","journal-title":"Int J Mol Cell Med"},{"key":"10543_CR108","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.phrs.2017.08.004","volume":"124","author":"MM Serafini","year":"2017","unstructured":"Serafini MM et al (2017) Curcumin in Alzheimer\u2019s disease: can we think to new strategies and perspectives for this molecule? Pharmacol Res 124:146\u2013155","journal-title":"Pharmacol Res"},{"issue":"15","key":"10543_CR109","first-page":"1955","volume":"34","author":"Z Zhang","year":"2009","unstructured":"Zhang Z et al (2009) [Protective effects of Catalpol against H2O2-induced oxidative damage in astrocytes]. Zhongguo Zhong Yao Za Zhi 34(15):1955\u20131958","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"10543_CR110","doi-asserted-by":"crossref","unstructured":"Wang Z et al (2018) Catalpol inhibits Amyloid-\u03b2 generation through promoting \u03b1-Cleavage of APP in Swedish mutant APP overexpressed N2a cells. Front Aging Neurosci, 10","DOI":"10.3389\/fnagi.2018.00066"},{"issue":"1","key":"10543_CR111","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3892\/mmr.2015.4496","volume":"13","author":"JZ Huang","year":"2016","unstructured":"Huang JZ et al (2016) Catalpol preserves neural function and attenuates the pathology of Alzheimer\u2019s disease in mice. Mol Med Rep 13(1):491\u2013496","journal-title":"Mol Med Rep"},{"issue":"17","key":"10543_CR112","first-page":"1771","volume":"32","author":"D Wan","year":"2007","unstructured":"Wan D et al (2007) [Study of Catalpol promoting axonal growth for cultured cortical neurons from rats]. Zhongguo Zhong Yao Za Zhi 32(17):1771\u20131774","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"issue":"2","key":"10543_CR113","first-page":"13","volume":"10","author":"N Saini","year":"2021","unstructured":"Saini N et al (2021) Therapeutic potential of Allium Sativum against the Abeta((1\u201340))-induced oxidative stress and mitochondrial dysfunction in the Wistar rats. Am J Neurodegener Dis 10(2):13\u201327","journal-title":"Am J Neurodegener Dis"},{"issue":"9","key":"10543_CR114","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1093\/jpp\/rgae069","volume":"76","author":"L Fang","year":"2024","unstructured":"Fang L et al (2024) Therapeutic effects of Tanshinone IIA and tetramethylpyrazine nanoemulsions on cognitive impairment and neuronal damage in Alzheimer\u2019s disease rat models. J Pharm Pharmacol 76(9):1169\u20131177","journal-title":"J Pharm Pharmacol"},{"issue":"Pt 2","key":"10543_CR115","first-page":"127923","volume":"254","author":"XQ Liu","year":"2024","unstructured":"Liu XQ et al (2024) Tanshinone IIA, the key compound in Salvia miltiorrhiza, improves cognitive impairment by upregulating Abeta-degrading enzymes in APP\/PS1 mice. Int J Biol Macromol 254(Pt 2):127923","journal-title":"Int J Biol Macromol"},{"issue":"11","key":"10543_CR116","first-page":"834","volume":"21","author":"CQ Zhu","year":"2001","unstructured":"Zhu CQ, Cao XD (2001) Regulatory effect of Tiaoxin recipe drug serum on animal\u2019s alzheimer disease related Tau protein phosphorylation]. Zhongguo Zhong Xi Yi Jie He Za Zhi 21(11):834\u2013836","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"issue":"5","key":"10543_CR117","first-page":"429","volume":"25","author":"HF Qiao","year":"2005","unstructured":"Qiao HF, Yang S, Zhou WX (2005) Inhibitory effect of active fraction of Tiaoxin recipe on beta-amyloid protein induced long-term potentiation in CA1 area of rats\u2019 hippocampal slices]. Zhongguo Zhong Xi Yi Jie He Za Zhi 25(5):429\u2013431","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"issue":"8","key":"10543_CR118","first-page":"583","volume":"23","author":"SM Lin","year":"2003","unstructured":"Lin SM, Wang J, Zhou RQ (2003) Clinical study on treatment of Alzheimer\u2019s disease from the viewpoint of Xin and Shen]. Zhongguo Zhong Xi Yi Jie He Za Zhi 23(8):583\u2013586","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"issue":"1","key":"10543_CR119","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.neulet.2010.09.079","volume":"487","author":"YY Li","year":"2011","unstructured":"Li YY et al (2011) Increased expression of miRNA-146a in Alzheimer\u2019s disease Transgenic mouse models. Neurosci Lett 487(1):94\u201398","journal-title":"Neurosci Lett"},{"key":"10543_CR120","doi-asserted-by":"crossref","unstructured":"Sokolik VV, Berchenko OG (2023) The cumulative effect of the combined action of miR-101 and Curcumin in a liposome on a model of Alzheimer\u2019s disease in mononuclear cells. Front Cell Neurosci, 17","DOI":"10.3389\/fncel.2023.1169980"},{"issue":"5","key":"10543_CR121","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1007\/s12640-022-00535-1","volume":"40","author":"HD Nguyen","year":"2022","unstructured":"Nguyen HD et al (2022) Curcumin-Attenuated TREM-1\/DAP12\/NLRP3\/Caspase-1\/IL1B, TLR4\/NF-\u03baB pathways, and Tau hyperphosphorylation induced by 1,2-Diacetyl benzene: an in vitro and in Silico study. Neurotox Res 40(5):1272\u20131291","journal-title":"Neurotox Res"},{"key":"10543_CR122","doi-asserted-by":"crossref","unstructured":"Meng S et al (2023) Catalpol Mitigates Alzheimer\u2019s Disease Progression by Promoting the Expression of Neural Stem Cell Exosomes Released miR-138-5p. Neurotox Res, 41(1): pp. 41\u201356","DOI":"10.1007\/s12640-022-00626-z"},{"issue":"6","key":"10543_CR123","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.joim.2019.09.002","volume":"17","author":"YR Hu","year":"2019","unstructured":"Hu YR et al (2019) Tiaoxin recipe, a Chinese herbal formula, inhibits microRNA-34a expression in the APPswe\/PS1DeltaE9 mouse model of Alzheimer\u2019s disease. J Integr Med 17(6):404\u2013409","journal-title":"J Integr Med"},{"issue":"1","key":"10543_CR124","doi-asserted-by":"crossref","first-page":"109","DOI":"10.23736\/S0026-4806.20.06463-0","volume":"113","author":"J Gong","year":"2022","unstructured":"Gong J, Sun D (2022) Study on the mechanism of Curcumin to reduce the inflammatory response of Temporal lobe in Alzheimer\u2019s disease by regulating miR-146a. Minerva Med 113(1):109\u2013118","journal-title":"Minerva Med"},{"key":"10543_CR125","doi-asserted-by":"crossref","unstructured":"Siedlecki-Wullich D, Minano-Molina AJ, Rodriguez-Alvarez J (2021) microRNAs as Early Biomarkers of Alzheimer\u2019s Disease: A Synaptic Perspective. Cells, 10(1)","DOI":"10.3390\/cells10010113"},{"issue":"6","key":"10543_CR126","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2174\/1381612827666211109113305","volume":"28","author":"AA Sayyed","year":"2022","unstructured":"Sayyed AA et al (2022) Role of MiRNAs in Cancer diagnostics and therapy: A recent update. Curr Pharm Des 28(6):471\u2013487","journal-title":"Curr Pharm Des"},{"key":"10543_CR127","doi-asserted-by":"crossref","unstructured":"Yu TW, Lane HY, Lin CH (2021) Novel Therapeutic Approaches for Alzheimer\u2019s Disease: An Updated Review. Int J Mol Sci, 22(15)","DOI":"10.3390\/ijms22158208"},{"key":"10543_CR128","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.phrs.2018.12.007","volume":"142","author":"J Du","year":"2019","unstructured":"Du J, Li M, Huang Q, Liu W, Li WQ, Li YJ, Gong ZC (2019) The critical role of MicroRNAs in stress response: therapeutic prospect and limitation. Pharmacol Res 142:294\u2013302","journal-title":"Pharmacol Res"},{"issue":"2","key":"10543_CR129","doi-asserted-by":"crossref","first-page":"242","DOI":"10.4103\/1673-5374.244784","volume":"14","author":"B Martinez","year":"2019","unstructured":"Martinez B, Peplow PV (2019) MicroRNAs as diagnostic and therapeutic tools for Alzheimer\u2019s disease: advances and limitations. Neural Regeneration Res 14(2):242\u2013255","journal-title":"Neural Regeneration Res"},{"key":"10543_CR130","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s40995-020-00870-y","volume":"44","author":"F Rezaee-Tazangi","year":"2020","unstructured":"Rezaee-Tazangi F, Varaa N, Khorsandi L, Abbaspour M (2020) Effects of silymarin-loaded polylactic-co-glycolic acid nanoparticles on osteoarthritis in rats. Iran J Sci Technol Trans A: Sci 44:605\u2013614","journal-title":"Iran J Sci Technol Trans A: Sci"},{"key":"10543_CR131","doi-asserted-by":"crossref","first-page":"102303","DOI":"10.1016\/j.nano.2020.102303","volume":"31","author":"M Mehta","year":"2021","unstructured":"Mehta M, Satija S, Paudel KR, Malyla V, Kannaujiya VK, Chellappan DK, Bebawy M, Hansbro PM, Wich PR, Dua K (2021) Targeting respiratory diseases using MiRNA inhibitor based nanotherapeutics: current status and future perspectives. Nanomed Nanotechnol Biol Med 31:102303","journal-title":"Nanomed Nanotechnol Biol Med"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10543-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-10543-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10543-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T16:35:40Z","timestamp":1766853340000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-10543-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,6]]},"references-count":131,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10543"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-10543-x","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,6]]},"assertion":[{"value":"23 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical issues (including plagiarism, data fabrication, double publication) have been completely observed by the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"445"}}